Kinesin Family Member 1C (KIF1C) Peptid
KIF1C
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle KIF1C Produkte
- KIF1C (Kinesin Family Member 1C (KIF1C))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-KIF1C antibody (Catalog #: ARP33913_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- KIF1C (Kinesin Family Member 1C (KIF1C))
- Synonyme
- KIF1C Peptide, ltxs1 Peptide, DKFZp468E0822 Peptide, LTXS1 Peptide, B430105J22Rik Peptide, D11Bwg1349e Peptide, Ltxs1 Peptide, kinesin family member 1C Peptide, KIF1C Peptide, kif1c Peptide, Kif1c Peptide
- Hintergrund
-
KIF1C represents a member of the Unc104 subfamily of kinesin-like proteins that are involved in the transport of mitochondria or synaptic vesicles in axons. KIF1C consists of an amino-terminal motor domain followed by a U104 domain and probably binds to target membranes through carboxyl-terminal sequences.
Alias Symbols: LTXS1
Protein Interaction Partner: CSNK2A1,CSNK2A2,KIF1C,PTPN21,YWHAB,YWHAE,YWHAG,YWHAZ,PTPN21,YWHAG
Protein Size: 1103 - Molekulargewicht
- 123 kDa
- Gen-ID
- 10749
- NCBI Accession
- NM_006612, NP_006603
- UniProt
- O43896
-
Sie sind hier:
